NBPF20

Across TCGA pan-cancer cohorts, NBPF20 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated NBPF20 data layer compared with 25 for mass-spec protein.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher NBPF20 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated NBPF20 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

ESCA are the cancer types where NBPF20 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	DFS	Median	II,III,IV	0.506	0.316	<.001	10	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

NBPF20–ESCA (DFS)

Open the ESCA breakdown →